Nyxoid 1.8 (Naloxone Nasal Spray) 1.8mg

Nyxoid 1.8 nasal spray contains naloxone, an opioid antagonist used to reverse opioid overdose effects. Ideal for emergency use, it quickly restores breathing in suspected opioid emergencies. Fast-acting and easy to administer, it’s a critical tool for opioid overdose response. Suitable for adults and children.

Strength

1.8mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Mundipharma Pty Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nyxoid 1.8 nasal spray is primarily used to reverse the life-threatening effects of opioid overdose, such as slowed or stopped breathing. It works by blocking opioid receptors in the brain, helping to restore normal respiration. This medication is intended for emergency use when opioid overdose is suspected, including cases involving prescription painkillers or illicit opioids like heroin. It is not a substitute for emergency medical care but provides crucial time for professional intervention.

Side Effects

When administered, Nyxoid 1.8 nasal spray typically begins working within minutes, helping to restore breathing in cases of opioid overdose. Users may experience a rapid return to consciousness or improved breathing effort. Some individuals might feel dizziness, nausea, or headache after use. These effects are generally temporary and linked to the reversal of opioid effects.

Precautions & Warnings

Nyxoid 1.8 should only be used if opioid overdose is suspected, as it may cause withdrawal symptoms in opioid-dependent individuals. Always call emergency services immediately after administration, even if the person responds. Keep the spray accessible in case a second dose is needed after 2–3 minutes if symptoms persist. Store at room temperature, away from direct sunlight and moisture.

Avoid Interactions

Nyxoid 1.8 may interact with other medications that affect breathing or the central nervous system, such as benzodiazepines or alcohol. It is not intended for use with non-opioid substances. If the person has taken multiple substances, naloxone may not fully reverse all effects. Always inform healthcare providers about recent substance use for accurate assessment.

Frequently Asked Questions

Use Nyxoid 1.8 if the person has slow, shallow, or no breathing, or if they are unresponsive after suspected opioid use.

Yes, Nyxoid 1.8 can be used on children, but the dose may need adjustment; always follow emergency medical guidance.

Effects typically begin within 2–5 minutes, with peak reversal usually within 10 minutes of administration.

A second dose may be needed after 2–3 minutes if breathing does not improve; always seek emergency care.

In many regions, Nyxoid 1.8 is available without a prescription for emergency use, but local regulations may vary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.